|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.170 HKD | 0.00% |
|
-1.59% | +22.18% |
Business description: Alibaba Health Information Technology Limited
Number of employees: 1,357
Sales by Activity: Alibaba Health Information Technology Limited
| Fiscal Period: March | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
Distribution and Development of Pharmaceutical and Healthcare | 15.52B | 20.58B | 26.76B | 27.03B | 30.6B |
Geographical breakdown of sales: Alibaba Health Information Technology Limited
| Fiscal Period: March | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
Mainland China | 14.87B | 20.11B | 26.76B | 27.03B | 30.6B |
Hong Kong | 645M | 465M | - | - | - |
Executive Committee: Alibaba Health Information Technology Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CEO | Chief Executive Officer | 47 | 27/11/2023 |
Yan Wu Tu
DFI | Director of Finance/CFO | 48 | 31/08/2019 |
Hiu Leong Tsui
SEC | Corporate Secretary | - | 11/08/2023 |
Yan Deng
SEC | Corporate Secretary | - | 11/08/2023 |
Composition of the Board of Directors: Alibaba Health Information Technology Limited
| Director | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CHM | Chairman | 47 | 14/12/2025 |
Yi Fei Huang
BRD | Director/Board Member | 53 | 08/06/2019 |
Yan Wu Tu
BRD | Director/Board Member | 48 | 22/10/2020 |
Jiaojiao Huang
BRD | Director/Board Member | 44 | 14/05/2023 |
Rong Shao
BRD | Director/Board Member | 64 | 10/08/2023 |
Yi Hong Wu
BRD | Director/Board Member | 58 | 10/08/2023 |
Haipeng Xu
BRD | Director/Board Member | 40 | 18/10/2023 |
Holdings: Alibaba Health Information Technology Limited
| Name | Equities | % | Valuation |
|---|---|---|---|
| 20,280,293 | 8.33% | 48 M $ | |
| 1,488,000 | 1.36% | 2 M $ |
Company details: Alibaba Health Information Technology Limited
Other Drug Retailers
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.59% | +9.79% | +8.25% | 12.76B | |
| +0.58% | -1.30% | +79.70% | +12.52% | 24.75B | |
| -7.09% | -4.17% | +13.59% | +17.52% | 7.16B | |
| -0.02% | -0.83% | -7.67% | +18.82% | 4.75B | |
| -1.69% | -3.14% | -5.43% | -27.95% | 4.28B | |
| -0.89% | -0.70% | -15.40% | -47.03% | 3.5B | |
| -1.44% | -2.14% | +25.38% | -37.24% | 3.17B | |
| -0.52% | +1.40% | -7.35% | +48.24% | 2.93B | |
| +0.94% | -1.24% | +69.42% | - | 2.12B | |
| -0.80% | +0.19% | +6.12% | +19.11% | 1.94B | |
| Average | -1.09% | +0.40% | +16.81% | +1.36% | 6.74B | |
| Weighted average by Cap. | -0.78% | +1.17% | +34.14% | +6.23% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 241 Stock
- Company Alibaba Health Information Technology Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition